RESUMO
Beditin, or 2-(2-amino-4-thiazolyl)-1,4-benzodioxane hydrochloride, is a new benzodioxane derivative possessing antihypoxant and alpha 2-adrenoreceptor blocker properties. In contrast to idazoxan, a well-known alpha 2-adrenoreceptor blocker, beditin (3 mg/kg) significantly increases the circulation rate and decreases the blood vessel resistance in various brain structures of rats and cats without considerably changing their systemic hemodynamic indices. Upon a one-side ligation of the common carotid artery in rats, beditin prevented a sharp increase in the lactate dehydrogenase activity and a growth in the content of free ammonia in the brain, which are characteristic of the ischemic states. The ammonia-eliminating effect of beditin is related to an increase in the glutamate dehydrogenase activity in the reductive amination reaction.
Assuntos
Antagonistas Adrenérgicos alfa/farmacologia , Encéfalo/metabolismo , Circulação Cerebrovascular/efeitos dos fármacos , Dioxanos/farmacologia , Receptores Adrenérgicos alfa 2/efeitos dos fármacos , Tiazóis/farmacologia , Animais , Velocidade do Fluxo Sanguíneo/efeitos dos fármacos , Encéfalo/irrigação sanguínea , Encéfalo/enzimologia , Gatos , Glutamato Desidrogenase/metabolismo , Hipóxia/prevenção & controle , Hipóxia-Isquemia Encefálica/metabolismo , Hipóxia-Isquemia Encefálica/fisiopatologia , Hipóxia-Isquemia Encefálica/prevenção & controle , L-Lactato Desidrogenase/metabolismo , Masculino , Músculo Esquelético/irrigação sanguínea , Músculo Esquelético/metabolismo , Ratos , Ratos Wistar , Pele/irrigação sanguínea , Pele/metabolismo , Resistência Vascular/efeitos dos fármacosRESUMO
GABA and its cyclic derivatives, gamma-butyrolactone and pyrrolidone-2, have been ascertained to abolish and prevent the cerebral vasoconstrictor effects of malonic dialdehyde. In this respect, gamma-butyrolactone excels pyrrolidone-2 and GABA, the effects of GABA being most slight. It may be suggested that the neuroactive amino acids exhibit antioxidative effects.
Assuntos
4-Butirolactona/farmacologia , Circulação Cerebrovascular/efeitos dos fármacos , Malondialdeído/antagonistas & inibidores , Pirrolidinonas/farmacologia , Vasoconstrição/efeitos dos fármacos , Ácido gama-Aminobutírico/farmacologia , Animais , Antioxidantes/farmacologia , Gatos , Interações Medicamentosas , Malondialdeído/farmacologiaRESUMO
The ability of pyroglutamic acid, a cyclic glutamic acid derivative, to increase cerebral blood flow, to decrease the resistance of brain vessels, and to relax the isolated grafts of cerebral arteries has been demonstrated. Pyroglutamic acid markedly stimulated brain metabolism: increased glucose uptake and utilization by cerebral tissues and decreased brain lactate dehydrogenase activity.
Assuntos
Artérias Cerebrais/efeitos dos fármacos , Artérias Cerebrais/metabolismo , Ácido Pirrolidonocarboxílico/farmacologia , Animais , Radioisótopos de Carbono , Gatos , Córtex Cerebral/irrigação sanguínea , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/metabolismo , Cães , Glucose/metabolismo , Técnicas In Vitro , L-Lactato Desidrogenase/efeitos dos fármacos , L-Lactato Desidrogenase/metabolismo , Ratos , Serotonina/farmacologia , Fatores de Tempo , Resistência Vascular/efeitos dos fármacosRESUMO
Malonic dialdehyde has a pronounced central vasoconstrictor effect, though when given in large doses, it causes a profound decrease in systemic blood pressure, however its vasoconstrictor effects are not directly related to fluctuations in systemic blood pressure. The universal antioxidant alpha-tocopherol acetate abolishes and prevents the central vasoconstrictor effects of malonic dialdehyde.
Assuntos
Artérias Cerebrais/efeitos dos fármacos , Malondialdeído/farmacologia , Vasoconstritores/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Gatos , Circulação Cerebrovascular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Frequência Cardíaca/efeitos dos fármacos , Malondialdeído/antagonistas & inibidores , Vasoconstritores/antagonistas & inibidores , Vitamina E/farmacologiaRESUMO
Pirrolidone-2, gamma-butyrolacton, succinic anhydride were found to possess pronounced antihypoxic activity that manifested itself in their ability to decrease the level of lactic acid accumulated during hypoxia. Pirrolidone-2 and succinic anhydride increase succinic dehydrogenase activity in vitro. At intraperitoneal administration the above mentioned compounds lead to lactate dehydrogenase activity inhibition under normal conditions while during circulatory hypoxia they stimulate lactate dehydrogenase reaction promoting the maintenance of energy balance of the cerebral tissue at the appropriate level.
Assuntos
Hipóxia Encefálica/tratamento farmacológico , Ácido gama-Aminobutírico/análogos & derivados , 4-Butirolactona/uso terapêutico , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Avaliação Pré-Clínica de Medicamentos , Hipóxia Encefálica/metabolismo , L-Lactato Desidrogenase/metabolismo , Lactatos/metabolismo , Ácido Láctico , Pirrolidinonas/uso terapêutico , Piruvatos/metabolismo , Ácido Pirúvico , Ratos , Succinato Desidrogenase/metabolismo , Anidridos Succínicos/uso terapêutico , Ácido gama-Aminobutírico/uso terapêuticoRESUMO
The efficiency was studied of rehabilitation of 115 patients with chronic bronchitis engaged in agricultural work under the effect of a complex of traditional health-resort climatic factors as well as this complex supplemented by breathing exercises with additional dead space or intensified graded physical exercises (cycling, running). Only the therapeutic complex including physical exercises proved efficient.
Assuntos
Doenças dos Trabalhadores Agrícolas/reabilitação , Bronquite/reabilitação , Doença Crônica , Terapia Combinada , Estâncias para Tratamento de Saúde , Humanos , UcrâniaRESUMO
The ability of cyclic GABA and GHBA derivatives--2-pyrrolidone and gamma-butyrolactone--to increase markedly the inclusion of 14C-leucine in the proteins of hypothalamus and cerebral arteries both normally and in condition of cerebral blood supply disturbances produced by unilateral 20 min ligation of a common carotid artery has been demonstrated.
Assuntos
4-Butirolactona/farmacologia , Encéfalo/efeitos dos fármacos , Artérias Cerebrais/efeitos dos fármacos , Furanos/farmacologia , Leucina/metabolismo , Proteínas do Tecido Nervoso/biossíntese , Pirrolidinonas/farmacologia , Animais , Encéfalo/metabolismo , Radioisótopos de Carbono , Artérias Cerebrais/metabolismo , Hipóxia Encefálica/metabolismo , RatosAssuntos
Banhos , Carbonatos/farmacologia , Coração/efeitos dos fármacos , Receptores Adrenérgicos/efeitos dos fármacos , Animais , Armênia , Catecolaminas/metabolismo , Masculino , Mitocôndrias Cardíacas/efeitos dos fármacos , Mitocôndrias Cardíacas/enzimologia , Monoaminoxidase/metabolismo , Miocárdio/metabolismo , Ratos , Receptores Adrenérgicos/metabolismoRESUMO
The ability of cyclic GABA derivative--pyrrolidone-2--to increase markedly cerebral blood flow both normally and in conditions of cerebral blood supply disturbances produced by unilateral 20-min ligation of a common carotid artery has been demonstrated. When pyrrolidone-2 administration accompanied bicuculline infusion (0.1 mg/kg) it did not provoke significant changes in the blood flow. Besides, bicuculline markedly weakened pyrrolidone-2 ability to relax the isolated grafts of cerebral arteries.
Assuntos
Circulação Cerebrovascular/efeitos dos fármacos , Pirrolidinonas/farmacologia , Animais , Bicuculina/farmacologia , Velocidade do Fluxo Sanguíneo/efeitos dos fármacos , Gatos , Cães , Interações Medicamentosas , Fatores de Tempo , Resistência Vascular/efeitos dos fármacosAssuntos
Circulação Cerebrovascular , Homeostase , Neurotransmissores/fisiologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Encéfalo/fisiologia , Gatos , Circulação Cerebrovascular/efeitos dos fármacos , Fenômenos Químicos , Físico-Química , Homeostase/efeitos dos fármacos , Humanos , Músculo Liso Vascular/efeitos dos fármacos , Músculo Liso Vascular/fisiologia , Neurotransmissores/antagonistas & inibidores , Receptores de GABA-A/efeitos dos fármacos , Receptores de GABA-A/fisiologia , Vasodilatação/efeitos dos fármacos , Ácido gama-Aminobutírico/fisiologiaRESUMO
A study was made of the contractility of smooth muscle cells of abdominal aorta strips of noninbred white rats with stable arterial hypertension induced by protracted intraperitoneal injection of cerebrosides isolated from cattle brain. It was demonstrated that as compared with normotensive animals, smooth muscle cells of the animals' arteries are characterized by the increased influx of extracellular calcium via slow potential-dependent calcium channels and hypersensitivity to noradrenaline and serotonin.
Assuntos
Cerebrosídeos/farmacologia , Hipertensão/induzido quimicamente , Contração Muscular/efeitos dos fármacos , Músculo Liso Vascular/efeitos dos fármacos , Animais , Aorta Abdominal/efeitos dos fármacos , Cálcio/metabolismo , Bovinos , Feminino , Hipertensão/fisiopatologia , Canais Iônicos/efeitos dos fármacos , Ratos , Fatores de TempoAssuntos
Banhos , Química Encefálica , Dióxido de Carbono , Epinefrina/análise , Norepinefrina/análise , Animais , Masculino , RatosRESUMO
Gangliosides interact with human serum albumin, inducing conformational changes in its globule. Gangliosides bring about an increase in the binding constant of the fluorescent probe 1-anilinonapthalene-8-sulfonate (ANS) with model phospholipid membranes, a decrease in the rate of pyrene diffusion in liposomes. Gangliosides raise the fluorescence intensity of ANS bound with the erythrocytic membrane as the binding constant of the probe-membrane increases, the fluorescence of tryptophanils of membranous proteins gets intensified, the fluorescence maximum of ANS and tryptophan residues shifts to the short-wave area, and the accessibility of tryptophan residues for NO-3 decreases. At the same time there is a reduction in the efficacy of energy migration from tryptophan to ANS and NAD X H2. The data obtained attest to the capability of gangliosides of influencing the conformation of both the lipid and protein phases of biological membranes.
Assuntos
Gangliosídeos/farmacologia , Lipídeos de Membrana , Proteínas de Membrana , Naftalenossulfonato de Anilina , Membrana Eritrocítica/efeitos dos fármacos , Corantes Fluorescentes , Humanos , Lipossomos , Membranas Artificiais , Fosfolipídeos , Conformação Proteica/efeitos dos fármacos , Albumina SéricaRESUMO
A neurochemical approach to a study of the mechanisms by which cerebral circulation is controlled made it possible to discover the capability of GABA, GHBA, gamma-butyrolactone and pyrrolidone-2 to enhance cerebral circulation, to relax and enlarge an isolated flap of the cerebral arteries. GABA and specific GABA-receptors were found in the tissues of the walls of the cerebral arteries. Glutamate decarboxylase and GABA-transaminase were discovered in the cerebral vessels, with the endothelial and muscle layers of the arterial walls showing the highest GABA-transaminase activity. It is evident that as regards certain biochemical characteristics there is a definite similarity between GABA-ergic neurons and tissues of cerebral artery walls, which may ensure similar and undirectional neurochemical reactions in the brain and in the walls of its arteries. The latter circumstance is responsible for the mechanisms that control the functioning of the cerebral vessels.
Assuntos
Encéfalo/metabolismo , Circulação Cerebrovascular , 4-Butirolactona/farmacologia , Animais , Artérias Cerebrais/efeitos dos fármacos , Artérias Cerebrais/enzimologia , Circulação Cerebrovascular/efeitos dos fármacos , Fibras Colinérgicas/metabolismo , Antagonistas GABAérgicos , Glutamato Descarboxilase/metabolismo , Hemodinâmica/efeitos dos fármacos , Homeostase , Humanos , Pirrolidinonas/farmacologia , Receptores de Superfície Celular/efeitos dos fármacos , Receptores de GABA-A , Oxibato de Sódio/farmacologia , Sistema Nervoso Simpático/fisiologia , Ácido gama-Aminobutírico/biossíntese , Ácido gama-Aminobutírico/fisiologiaRESUMO
It was found that GABA and sodium hydroxybutyrate are capable to prevent gastric ulcers. While protecting the animals from experimental ulcers both the substances display an ability to increase the content of ATP in the gastric wall. ATP that prevents the occurrence of experimental gastric ulcers enhances 14-leucine incorporation into proteins of gastric tissues. It was demonstrated in experiments ulcer prevention that under the effect of 32P-ATP the content of phosphorylated proteins in gastric tissues rises more than 2-fold. This circumstances ensures the increased resistance of the gastric mucosa to the action of proteolytic enzymes. Enhancement of oxygen consumption by the tissues should be also regarded as one of the factors determining high resistance of the mucosa to proteolysis.